BiologicalDrug
Rilogrotug clinical trials
Also written AV-380.
- studies test it
- 3
- open now
- 2
- in phase 3
- 1
- first study started
- 2021
Keep track of what changes. Save the rilogrotug studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
2 studies that test it; most in 2021 (1); 1 more planned to start later
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses rilogrotug is read from its arms, and is right about nine times in ten.
Testing it · 3
- OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingPhase 2/3AVEO Pharmaceuticals, Inc.NCT07888075Written as Rilogrotug
- A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaRecruitingPhase 1AVEO Pharmaceuticals, Inc.NCT05865535Written as AV-380
- A Phase 1 Study of AV-380 in Healthy SubjectsCompletedPhase 1AVEO Pharmaceuticals, Inc.NCT04815551Written as AV-380
Codes
What other systems call rilogrotug · ClinicalTrials.gg INT017186
- UNII (FDA) LI86LS4ZURRILOGROTUGOne source FDA
- NCI Thesaurus C200801RilogrotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LI86LS4ZUR | RILOGROTUG | One source FDA |
| NCI Thesaurus | C200801 | Rilogrotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.